These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32981025)

  • 1. Eculizumab treatment for renal failure in a pediatric patient with COVID-19.
    Mahajan R; Lipton M; Broglie L; Jain NG; Uy NS
    J Nephrol; 2020 Dec; 33(6):1373-1376. PubMed ID: 32981025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic.
    Tatar E; Erdi ZC; Ozgur O; Tasdemir A; Tatar B
    Int Urol Nephrol; 2022 Feb; 54(2):459-460. PubMed ID: 34003430
    [No Abstract]   [Full Text] [Related]  

  • 3. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
    Boudhabhay I; Rabant M; Roumenina LT; Coupry LM; Poillerat V; Marchal A; Frémeaux-Bacchi V; El Karoui K; Monchi M; Pourcine F
    Front Immunol; 2021; 12():680567. PubMed ID: 34248962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic Microangiopathy Triggered by COVID-19: Case Reports.
    Korotchaeva J; Chebotareva N; Andreeva E; Sorokin Y; McDonnell V; Stolyarevich E; Moiseev S
    Nephron; 2022; 146(2):197-202. PubMed ID: 34808629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
    Araten DJ; Belmont HM; Schaefer-Cutillo J; Iyengar A; Mattoo A; Reddy R
    Am J Case Rep; 2020 Sep; 21():e927418. PubMed ID: 32917848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
    Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
    Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA; Fila M; Ardissino G; Al-Akash SI; Evans J; Henning P; Lieberman KV; Maringhini S; Pape L; Rees L; van de Kar NC; Vande Walle J; Ogawa M; Bedrosian CL; Licht C
    Kidney Int; 2016 Mar; 89(3):701-11. PubMed ID: 26880462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
    Schüller H; Klein F; Lübbert M; Prager EP
    Ann Hematol; 2021 Mar; 100(3):841-842. PubMed ID: 33170342
    [No Abstract]   [Full Text] [Related]  

  • 9. The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARSCoV2 infection and multisystem inflammatory syndrome in children.
    Aurora T; Joseph N; Bhoopalan SV; Caniza MA; Flerlage T; Ghafoor S; Hankins J; Hijano DR; Jesudas R; Kirkham J; Martinez H; Alfaro GM; Sharma A; Hines M
    Haematologica; 2022 Oct; 107(10):2517-2522. PubMed ID: 35615927
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience.
    Rombolà G; Heidempergher M; Cornacchiari M; Baragetti I; Pieruzzi F;
    J Nephrol; 2021 Apr; 34(2):277-279. PubMed ID: 33646561
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19-related stigma and perceived stress among dialysis staff.
    Uvais NA; Aziz F; Hafeeq B
    J Nephrol; 2020 Dec; 33(6):1121-1122. PubMed ID: 32804354
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent allograft C3 glomerulonephritis and unsuccessful eculizumab treatment.
    Kaartinen K; Martola L; Räisänen-Sokolowski A; Meri S
    Clin Immunol; 2018 Feb; 187():104-106. PubMed ID: 29097196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late renal recovery after treatment over 1 year post-onset in an atypical hemolytic uremic syndrome: a case report.
    Kuroki Y; Mitsuiki K; Nakagawa K; Tsuruya K; Katafuchi R; Hirakata H; Nakano T
    BMC Nephrol; 2020 Jun; 21(1):236. PubMed ID: 32571244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.
    Genere L; Bacchetta J; Bertrand Y; Javouhey E; Cheikh N; Sellier-Leclerc AL
    Arch Pediatr; 2018 Nov; 25(8):485-488. PubMed ID: 30340942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
    Wright RD; Bannerman F; Beresford MW; Oni L
    BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P; Netti GS; Santangelo L; Castellano G; Carbone V; Torres DD; Martino M; Sesta M; Di Cuonzo F; Resta MC; Gaeta A; Milella L; Chironna M; Germinario C; Scavia G; Gesualdo L; Giordano M
    Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria.
    Pravdic Z; Mitrovic M; Bogdanovic A; Virijevic M; Sabljic N; Pantic N; Vukovic NS
    Hamostaseologie; 2021 Oct; 41(5):397-399. PubMed ID: 34544179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience.
    Kant S; Bhalla A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 May; 21(1):189. PubMed ID: 32434487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The COVID-19 pandemic and hemodialysis: a multicentric experience].
    Previti A; Lentini P; Di Caprio A; Marchiori M; Dell'Aquila R
    G Ital Nefrol; 2020 Dec; 37(6):. PubMed ID: 33295703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.